✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Brexpiprazole

Brexpiprazole

CAS 913611-97-9C25H27N3O2SMW 433.6

Brexpiprazole (CAS 913611-97-9) — formula C25H27N3O2S, molecular weight 433.6.

Product Overview

CAS Number913611-97-9
Molecular FormulaC25H27N3O2S
Molecular Weight433.6
Melting Point135.1
Boiling Point675.2
LogP4.7

Technical Profile

What this product is

Brexpiprazole is a chemical compound with CAS registry number 913611-97-9 and molecular formula C25H27N3O2S (molecular weight 433.6).

Identification

CAS number: 913611-97-9

Its molecular formula C25H27N3O2S comprises 25 C, 27 H, 3 N, 2 O, 1 S atoms.

Also known as: Brexpiprazole · 布瑞哌唑

Frequently Asked Questions

What is the CAS number of Brexpiprazole?

The CAS registry number of Brexpiprazole is 913611-97-9.

What is the molecular formula and molecular weight of Brexpiprazole?

Molecular formula C25H27N3O2S, molecular weight 433.6.

What other names is Brexpiprazole known by?

It is also registered under: Brexpiprazole, 布瑞哌唑.

PubChem Public Data

Independent reference data for Brexpiprazole (CAS 913611-97-9), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number913611-97-9
PubChem CID11978813
Molecular formulaC25H27N3O2S
IUPAC name7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one
UNII (FDA)2J3YBM1K8C

Computed descriptors

Molecular Weight433.6
XLogP34.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count7
Exact Mass433.18239829
Monoisotopic Mass433.18239829
Topological Polar Surface Area73.1
Heavy Atom Count31

Physicochemical values on record

Boiling Point675.2
Melting Point135.1

Documented uses on record

    Brexpiprazole is indicated as adjunctive therapy to antidepressants for the treatment of major depressive disorder in adults. It is also indicated for the treatment of schizophrenia in patients 13 years of age and older. Brexpiprazole is also indicated for the treatment of agitation associated with dementia due to Alzheimer’s disease; however, it is not indicated as an as-needed (“prn”) treatment for this condition.Brexpiprazole is an atypical antipsychotic used in the treatment of schizophrenia and major depressive disorders. Brexpiprazole has been associated with a low rate of serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent acute liver injury.

    Synonyms and trade names

    BREXPIPRAZOLE; 913611-97-9; Rexulti; OPC-34712; OPC 34712; brexpiprazol; 7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one; 2J3YBM1K8C; 7-(4-(4-(1-Benzothiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one; DTXSID40238527; 7-{4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy}-1,2-dihydroquinolin-2-one; brexpiprazolum; 7-(4-(4-(1-benzothiophen-4-yl)piperazin-1-yl)butoxy)-1H-quinolin-2-one; 7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one; 7-(4-(4-(1-benzothiophen-4-yl)piperazin-1-yl)butoxy)-1,2-dihydroquinolin-2-one; RefChem:58868

    GHS hazard classification

    Reported hazard statementsH302 (96.6%), H351 (98.3%), H360 (96.6%), H362 (98.3%), H372 (96.6%), H400 (96.6%), H410 (98.3%), H361 (100%)

    H302 (96.6%): Harmful if swallowed [Warning Acute toxicity, oral]

    H351 (98.3%): Suspected of causing cancer [Warning Carcinogenicity]

    What the public record says

    Brexpiprazole · CAS 913611-97-9 · C25H27N3O2S. UNII 2J3YBM1K8C. Boiling Point: 675.2; Melting Point: 135.1.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 布瑞哌唑

鲁ICP备19031700号-2